Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences ...

The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million with non equity based funding of close to 50% The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million with non equity based funding of close to 50% , May 23, 2013 /PRNewswire/ -- Hadasit ... (more)

http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Hadasit-Bio-Holdings-Ltd-Portfolio-Company---Cell-/ArticleNewsFeed/Article/detail/814039?ref=25